SPC Samlip Co., Ltd. (KRX:005610)
South Korea · Delayed Price · Currency is KRW 49,550
+350 (0.71%)
At close: Apr 8, 2026
SPC Samlip Revenue
In the year 2025, SPC Samlip had annual revenue of 3.37T KRW, down -1.68%. SPC Samlip had revenue of 869.01B in the quarter ending December 31, 2025, a decrease of -3.73%.
Revenue
3.37T
Revenue Growth
-1.68%
P/S Ratio
0.12
Revenue / Employee
1.21B
Employees
2,791
Market Cap
401.21B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.37T | -57.44B | -1.68% |
| Dec 31, 2024 | 3.43T | -5.40B | -0.16% |
| Dec 31, 2023 | 3.43T | 118.78B | 3.58% |
| Dec 31, 2022 | 3.31T | 367.89B | 12.49% |
| Dec 31, 2021 | 2.95T | 403.94B | 15.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Daesang Holdings | 5.63T |
| Sajodaerim | 3.50T |
| EASY HOLDINGS | 3.39T |
| Pulmuone Corporate | 3.38T |
| Samyang | 2.56T |
| Maeil Dairies | 1.84T |
| Kwang Dong Pharmaceutical | 1.66T |
| Binggrae | 1.49T |